Cytogen Statistics

Total Valuation

Cytogen has a market cap or net worth of KRW 81.32 billion. The enterprise value is 55.29 billion.

Market Cap	81.32B
Enterprise Value	55.29B

Important Dates

The last earnings date was Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Cytogen has 23.07 million shares outstanding. The number of shares has increased by 23.44% in one year.

Current Share Class	n/a
Shares Outstanding	23.07M
Shares Change (YoY)	+23.44%
Shares Change (QoQ)	+1.58%
Owned by Insiders (%)	18.32%
Owned by Institutions (%)	0.03%
Float	11.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.30
PB Ratio	1.67
P/TBV Ratio	2.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.23
EV / Sales	5.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.25

Financial Position

The company has a current ratio of 10.20, with a Debt / Equity ratio of 0.30.

Current Ratio	10.20
Quick Ratio	9.71
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-1.41
Interest Coverage	-5.10

Financial Efficiency

Return on equity (ROE) is -33.46% and return on invested capital (ROIC) is -9.89%.

Return on Equity (ROE)	-33.46%
Return on Assets (ROA)	-9.07%
Return on Invested Capital (ROIC)	-9.89%
Return on Capital Employed (ROCE)	-15.74%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	51
Asset Turnover	0.15
Inventory Turnover	9.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.32% in the last 52 weeks. The beta is 0.17, so Cytogen's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-72.32%
50-Day Moving Average	4,333.40
200-Day Moving Average	6,597.85
Relative Strength Index (RSI)	25.42
Average Volume (20 Days)	57,737

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cytogen had revenue of KRW 10.91 billion and -17.12 billion in losses. Loss per share was -758.00.

Revenue	10.91B
Gross Profit	2.83B
Operating Income	-10.67B
Pretax Income	-17.93B
Net Income	-17.12B
EBITDA	-8.58B
EBIT	-10.67B
Loss Per Share	-758.00

Full Income Statement

Balance Sheet

The company has 41.27 billion in cash and 14.87 billion in debt, giving a net cash position of 26.39 billion or 1,144.13 per share.

Cash & Cash Equivalents	41.27B
Total Debt	14.87B
Net Cash	26.39B
Net Cash Per Share	1,144.13
Equity (Book Value)	48.94B
Book Value Per Share	2,109.65
Working Capital	43.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -9.53 billion and capital expenditures -1.01 billion, giving a free cash flow of -10.54 billion.

Operating Cash Flow	-9.53B
Capital Expenditures	-1.01B
Free Cash Flow	-10.54B
FCF Per Share	-456.70

Full Cash Flow Statement

Margins

Gross margin is 25.93%, with operating and profit margins of -97.75% and -156.88%.

Gross Margin	25.93%
Operating Margin	-97.75%
Pretax Margin	-164.35%
Profit Margin	-156.88%
EBITDA Margin	-78.61%
EBIT Margin	-97.75%
FCF Margin	n/a

Dividends & Yields

Cytogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.44%
Shareholder Yield	-23.44%
Earnings Yield	-21.05%
FCF Yield	-12.96%

Stock Splits

The last stock split was on September 28, 2022. It was a forward split with a ratio of 3.

Last Split Date	Sep 28, 2022
Split Type	Forward
Split Ratio	3

Scores

Cytogen has an Altman Z-Score of 4.28.

Altman Z-Score	4.28
Piotroski F-Score	n/a